Tissue regeneration and homeostasis through functional Met/HGF receptor modification associated with tissue injury.

通过与组织损伤相关的功能性 Met/HGF 受体修饰来实现组织再生和稳态。

基本信息

  • 批准号:
    13470037
  • 负责人:
  • 金额:
    $ 6.72万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

HGF is involved in regeneration of various tissues, including the liver. HGF exerts its biological activities in injured tissue-specific manner, whereas mechanisms involved in the injured tissue-specific responsiveness/activation of the c-Met remain unknown. Elucidation of injured tissue-specific c-Met activation is expected to lead to understanding of fundamental mechanisms of tissue regeneration and homeostasis. This research focused to elucidate regulatory mechanisms for c-Met receptor function in signal transduction and their significance in tissue regeneration and homeostasis.1.Regulation of cellular responsiveness associated with c-Met Ser985 phosphorylation :We found that 1) c-Met receptor tyrosine phosphorylation/activation upon HGF-stimulus is regulated with a reciprocal manner to c-Met Ser985 phosphorylation, 2) c-Met Ser985 phosphorylation is bidirectionally regulated by PKC and PP2A (protein phosphatase-2A), i.e., it is phosphorylated by PKC instead dephosphorylated by PP2A … More , and 3) c-Met Ser985 phosphorylation is induced oxidative stress of cells these cells wherein c-Met Ser985 is phosphorylated are incapable of responding to extracellular HGF-stimulus. In addition, c-Met Ser985 phosphorylation is regulated through cell-cell adhesiveness in hepatocytes in primary culture, suggesting that change in cell-cell adhesiveness in response to tissue and cellular injury may affect Ser985 phosphorylation, thereby regulating cellular responsiveness to HGF.2.Analysis of physiological significance of c-Met receptor juxtamembrane region including Ser985 through transgenic mice :The juxtamembrane region of the c-Met receptor contains Ser985 and is considered to be negative regulatory domain for HGF-dependent tyrosine phosphorylation. To elucidate physiological significance of the negative regulation of c-Met receptor function, we planned to prepare genetically modified mice (knock-in mice) wherein mutated c-Met receptor deleted with the juxtamembrane (Δjxt-c-Met) is expressed, instead of full-length c-Met. ES cells having knock-in constract were selected and chimeric mice were obtained.3.In vivo injured tissue-specific activation of c-Met and its relationship to Ser985 phosphorylation:c-Met receptor tyrosine phosphorylation was induced in the injured liver 24-48 hr after CC14-administration in mice, whereas c-Met receptor was not activated in intact organs. Instead, c-Met Ser985 was phosphorylated in intact liver, whereas it was dephosphorylated 24-48 hr after liver injury. Thus, c-Met Ser985 and c-Met tyrosine phosphorylation is reciprocally regulated in response to tissue injury, suggesting that Ser985 phosphorylation is a mechanism responsible for injured tissue-specific modification of the c-Met receptor function.4.Discussion :Ser985 phosphorylation mediated by activation of PKC and PP2A is likely to play a role in the regulation of c-Met receptor activation and cellular responsiveness to HGF, which depend on the extracellular environment and stimuli. Further studies on regulatory mechanisms responsible for c-Met receptor activation through juxtamembrane domain and Ser985 phosphorylation will provide even further understanding of the HGF-c-Met system in development, tissue regeneration, and tumorigenesis. Less
HGF 参与多种组织的再生,包括肝脏,以受损组织特异性方式发挥其生物活性,而参与受损组织特异性反应/c-Met 激活的机制仍不清楚。特异性 c-Met 激活有望促进对组织再生和稳态的基本机制的理解。这项研究的重点是阐明 c-Met 受体功能在信号转导中的调节机制及其在组织再生和稳态中的意义。 1. 与 c-Met Ser985 磷酸化相关的细胞反应性调节:我们发现 1) HGF 刺激后的 c-Met 受体酪氨酸磷酸化/激活以与 c-Met Ser985 磷酸化相反的方式进行调节,2) c- Met Ser985 磷酸化受 PKC 和 PP2A(蛋白质磷酸酶-2A),即它被 PKC 磷酸化,而不是被 PP2A 去磷酸化……更多,以及 3)c-Met Ser985 磷酸化会诱导细胞的氧化应激,因此这些细胞中的 c-Met Ser985 磷酸化无法对细胞外 HGF- 做出反应此外,c-Met Ser985 磷酸化是通过细胞间调节的。原代培养物中肝细胞的粘附性,表明响应组织和细胞损伤的细胞间粘附性的变化可能影响 Ser985 磷酸化,从而调节细胞对 HGF 的反应性。 2. 通过分析 c-Met 受体近膜区(包括 Ser985)的生理意义转基因小鼠:c-Met受体的近膜区含有Ser985,被认为是HGF依赖性酪氨酸的负调节结构域为了阐明c-Met受体功能负调节的生理意义,我们计划制备表达缺失近膜的突变c-Met受体(Δjxt-c-Met)的基因改造小鼠(敲入小鼠),选择具有敲入构建体的ES细胞代替全长c-Met,获得嵌合小鼠。3.c-Met体内损伤组织特异性激活及其与体内损伤的关系。 Ser985 磷酸化:给予小鼠 CC14 后 24-48 小时,在受损肝脏中诱导 c-Met 受体酪氨酸磷酸化,而在完整器官中 c-Met 受体未激活,相反,c-Met Ser985 在完整肝脏中被磷酸化。而在肝损伤后 24-48 小时,c-Met Ser985 和 c-Met 酪氨酸被去磷酸化。磷酸化在组织损伤时相互调节,表明 Ser985 磷酸化是一种负责损伤组织特异性修饰 c-Met 受体功能的机制。 4.讨论:PKC 和 PP2A 激活介导的 Ser985 磷酸化很可能发挥重要作用。 c-Met 受体激活和细胞对 HGF 反应的调节作用,这取决于细胞外环境和刺激的调节机制的进一步研究。通过近膜结构域和 Ser985 磷酸化激活 c-Met 受体将进一步了解 HGF-c-Met 系统在发育、组织再生和肿瘤发生中的作用。

项目成果

期刊论文数量(537)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sumi, T., Matsumoto, K., Nakamura, T.: "Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase."J Biol Chem.. 276. 670-676 (2001)
Sumi, T.、Matsumoto, K.、Nakamura, T.:“通过 ROCK(一种 Rho 依赖性蛋白激酶)磷酸化苏氨酸 505 来特异性激活 LIM 激酶 2。”J Biol Chem.. 276. 670-676 (2001
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsumoto, K., Morishita, R., Tomita, N., Moriguchi, A., Yamasaki, K., Aoki, M., Matsumoto, K., Nakamura, T., Higaki, J., Ogihara, T.: "Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin 12 anal
松本 K.、森下 R.、富田 N.、森口 A.、山崎 K.、青木 M.、松本 K.、中村 T.、桧垣 J.、荻原 T.:
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hayashi, K., Morishita, R., Nakagami, H., Yoshimura, S., Hara, A., Matsumoto, K., Nakamura, T., Ogihara, T., Kaneda, Y., Sakai, N.: "Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid sp
Hayashi, K.、Morishita, R.、Nakagami, H.、Yoshimura, S.、Hara, A.、Matsumoto, K.、Nakamura, T.、Ogihara, T.、Kaneda, Y.、Sakai, N.:
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kubota, T, Fujiwara, H., Amaike, H., Takashima, K., Inada, S., Atsuji, K., Yoshimura, M., Matsumoto, K., Nakamura, T., Yamagishi., H.: "Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with an
久保田 T、藤原 H.、天池 H.、高岛 K.、稻田 S.、厚二 K.、吉村 M.、松本 K.、中村 T.、山岸 H.:
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Wen, J., Matsumoto, K., Taniura, N., Tomioka, D., Nakamura, T.: "Hepatic gene expression of NK4, an HGF-antagonist/angio-genesis inhibitor suppresses liver metastasis and invasive growth of colon cancer in mice."Cancer Gene Therapy. (in press).
Wen, J.、Matsumoto, K.、Taniura, N.、Tomioka, D.、Nakamura, T.:“NK4(一种 HGF 拮抗剂/血管生成抑制剂)的肝基因表达可抑制结肠癌的肝转移和侵袭性生长
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUMOTO Kunio其他文献

MATSUMOTO Kunio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUMOTO Kunio', 18)}}的其他基金

Mechanisms for malignant tumor progression based on acquisition of 3-D invasiveness and regulation of epithelial morphogenesis
基于 3D 侵袭性获取和上皮形态发生调节的恶性肿瘤进展机制
  • 批准号:
    24300329
  • 财政年份:
    2012
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on tissue regeneration regulated by Met/HGF receptor ON-OFF regulation
Met/HGF受体ON-OFF调控的组织再生研究
  • 批准号:
    20390077
  • 财政年份:
    2008
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of tissue regeneration and homeostasis through ON-OFFcontrol of the Met/HGF receptor
通过 Met/HGF 受体的 ON-OFF 控制来调节组织再生和体内平衡
  • 批准号:
    18570127
  • 财政年份:
    2006
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a high-sensitive method of γ-aminobutyric acid with a novel γ-aminobutyric acid oxidase
使用新型γ-氨基丁酸氧化酶开发γ-氨基丁酸的高灵敏度方法
  • 批准号:
    15560680
  • 财政年份:
    2003
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular regulation by kringles of HGF and molecular cloning of a novel kringle-containing protein
HGF 的三环对血管的调节以及一种新型三环蛋白的分子克隆
  • 批准号:
    11680631
  • 财政年份:
    1999
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anti-fibrogenic analysis of HGF in intractable organ failures: Clinical potential of HGF as regenerative therapy
HGF 在顽固性器官衰竭中的抗纤维形成分析:HGF 作为再生疗法的临床潜力
  • 批准号:
    11557010
  • 财政年份:
    1999
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Roles of HGF and its family molecules in development.
HGF 及其家族分子在发育中的作用。
  • 批准号:
    07044201
  • 财政年份:
    1995
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
INDUCTION OF HGF AFTER LIVER INJURIES AND IDENTIFICATION OF INDUCER FOR HGF
肝损伤后 HGF 的诱导以及 HGF 诱导剂的鉴定
  • 批准号:
    03680173
  • 财政年份:
    1991
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

螺旋层状结构的矿化纤维素纳米晶材料的仿生构建及其促牙槽骨组织再生的机制研究
  • 批准号:
    82301152
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
生物力学传导通路mechano-YAP/TAZ对放射损伤引起的勃起功能障碍中组织再生和功能修复的研究
  • 批准号:
    82373525
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于上皮间充质转化进程探讨Cd44在长期机械牵张介导组织扩张治疗再生能力耗竭中的作用和机制
  • 批准号:
    82372534
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
双重调控巨噬细胞的左旋手性核苷超分子水凝胶在炎性环境下牙周组织再生中的作用及机制研究
  • 批准号:
    82301149
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于“免疫-血管-半月板再生”机制构建负泊松比和结构/细胞双重梯度仿生不同区域的组织工程半月板
  • 批准号:
    82372490
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

HGF and Signaling Pathways in Hepatic Tissue Assembly
HGF 和肝组织组装中的信号通路
  • 批准号:
    8259209
  • 财政年份:
    2004
  • 资助金额:
    $ 6.72万
  • 项目类别:
HGF and Signaling Pathways in Hepatic Tissue Assembly
HGF 和肝组织组装中的信号通路
  • 批准号:
    7196476
  • 财政年份:
    2004
  • 资助金额:
    $ 6.72万
  • 项目类别:
HGF and Signaling Pathways in Hepatic Tissue Assembly
HGF 和肝组织组装中的信号通路
  • 批准号:
    8462213
  • 财政年份:
    2004
  • 资助金额:
    $ 6.72万
  • 项目类别:
HGF and Signaling Pathways in Hepatic Tissue Assembly
HGF 和肝组织组装中的信号通路
  • 批准号:
    8081865
  • 财政年份:
    2004
  • 资助金额:
    $ 6.72万
  • 项目类别:
HGF and Signaling Pathways in Hepatic Tissue Assembly
HGF 和肝组织组装中的信号通路
  • 批准号:
    7996306
  • 财政年份:
    2004
  • 资助金额:
    $ 6.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了